These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 30509602)

  • 21. CYR61, a potential biomarker of tumor inflammatory response in epithelial ovarian cancer microenvironment of tumor progress.
    Shi J; Huo R; Li N; Li H; Zhai T; Li H; Shen B; Ye J; Fu R; Di W
    BMC Cancer; 2019 Nov; 19(1):1140. PubMed ID: 31766991
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Malignant ascites determine the transmesothelial invasion of ovarian cancer cells.
    Mikuła-Pietrasik J; Uruski P; Szubert S; Szpurek D; Sajdak S; Tykarski A; Książek K
    Int J Biochem Cell Biol; 2017 Nov; 92():6-13. PubMed ID: 28888784
    [TBL] [Abstract][Full Text] [Related]  

  • 23. CCL18 from ascites promotes ovarian cancer cell migration through proline-rich tyrosine kinase 2 signaling.
    Lane D; Matte I; Laplante C; Garde-Granger P; Carignan A; Bessette P; Rancourt C; Piché A
    Mol Cancer; 2016 Sep; 15(1):58. PubMed ID: 27613122
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Glutathione peroxidase 3 is a candidate mechanism of anticancer drug resistance of ovarian clear cell adenocarcinoma.
    Saga Y; Ohwada M; Suzuki M; Konno R; Kigawa J; Ueno S; Mano H
    Oncol Rep; 2008 Dec; 20(6):1299-303. PubMed ID: 19020706
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Malignant ascites occurs most often in patients with high-grade serous papillary ovarian cancer at initial diagnosis: a retrospective analysis of 191 women treated at Bayreuth Hospital, 2006-2015.
    Krugmann J; Schwarz CL; Melcher B; Sterlacci W; Ozalinskaite A; Lermann J; Agaimy A; Vieth M
    Arch Gynecol Obstet; 2019 Feb; 299(2):515-523. PubMed ID: 30415435
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Ovarian carcinoma ascites spheroids adhere to extracellular matrix components and mesothelial cell monolayers.
    Burleson KM; Casey RC; Skubitz KM; Pambuccian SE; Oegema TR; Skubitz AP
    Gynecol Oncol; 2004 Apr; 93(1):170-81. PubMed ID: 15047232
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Tumor suppressor function of the plasma glutathione peroxidase gpx3 in colitis-associated carcinoma.
    Barrett CW; Ning W; Chen X; Smith JJ; Washington MK; Hill KE; Coburn LA; Peek RM; Chaturvedi R; Wilson KT; Burk RF; Williams CS
    Cancer Res; 2013 Feb; 73(3):1245-55. PubMed ID: 23221387
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Immune Tumor Microenvironment in Ovarian Cancer Ascites.
    Almeida-Nunes DL; Mendes-Frias A; Silvestre R; Dinis-Oliveira RJ; Ricardo S
    Int J Mol Sci; 2022 Sep; 23(18):. PubMed ID: 36142615
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Glutathione peroxidase 3 (GPX3) suppresses the growth of melanoma cells through reactive oxygen species (ROS)-dependent stabilization of hypoxia-inducible factor 1-α and 2-α.
    Yi Z; Jiang L; Zhao L; Zhou M; Ni Y; Yang Y; Yang H; Yang L; Zhang Q; Kuang Y; Deng M; Zhu Y
    J Cell Biochem; 2019 Nov; 120(11):19124-19136. PubMed ID: 31310363
    [TBL] [Abstract][Full Text] [Related]  

  • 30. MiR-921 directly downregulates GPx3 in A549 lung cancer cells.
    Choi JY; An BC; Jung IJ; Kim JH; Lee SW
    Gene; 2019 Jun; 700():163-167. PubMed ID: 30898707
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Acidic ascites inhibits ovarian cancer cell proliferation and correlates with the metabolomic, lipidomic and inflammatory phenotype of human patients.
    Yang Q; Bae G; Nadiradze G; Castagna A; Berezhnoy G; Zizmare L; Kulkarni A; Singh Y; Weinreich FJ; Kommoss S; Reymond MA; Trautwein C
    J Transl Med; 2022 Dec; 20(1):581. PubMed ID: 36503580
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Modulation of AKT activity is associated with reversible dormancy in ascites-derived epithelial ovarian cancer spheroids.
    Correa RJ; Peart T; Valdes YR; DiMattia GE; Shepherd TG
    Carcinogenesis; 2012 Jan; 33(1):49-58. PubMed ID: 22045027
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Insights into the role of GPX3, a highly efficient plasma antioxidant, in cancer.
    Nirgude S; Choudhary B
    Biochem Pharmacol; 2021 Feb; 184():114365. PubMed ID: 33310051
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Microparticles from ovarian carcinomas are shed into ascites and promote cell migration.
    Press JZ; Reyes M; Pitteri SJ; Pennil C; Garcia R; Goff BA; Hanash SM; Swisher EM
    Int J Gynecol Cancer; 2012 May; 22(4):546-52. PubMed ID: 22315094
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Syngeneic Murine Ovarian Cancer Model Reveals That Ascites Enriches for Ovarian Cancer Stem-Like Cells Expressing Membrane GRP78.
    Mo L; Bachelder RE; Kennedy M; Chen PH; Chi JT; Berchuck A; Cianciolo G; Pizzo SV
    Mol Cancer Ther; 2015 Mar; 14(3):747-56. PubMed ID: 25589495
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Ovarian cancer ascites protects from TRAIL-induced cell death through alphavbeta5 integrin-mediated focal adhesion kinase and Akt activation.
    Lane D; Goncharenko-Khaider N; Rancourt C; Piché A
    Oncogene; 2010 Jun; 29(24):3519-31. PubMed ID: 20400979
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The Epithelial-Mesenchymal Transition Initiated by Malignant Ascites Underlies the Transmesothelial Invasion of Ovarian Cancer Cells.
    Pakuła M; Mikuła-Pietrasik J; Witucka A; Kostka-Jeziorny K; Uruski P; Moszyński R; Naumowicz E; Sajdak S; Tykarski A; Książek K
    Int J Mol Sci; 2019 Jan; 20(1):. PubMed ID: 30609691
    [TBL] [Abstract][Full Text] [Related]  

  • 38. GPX3 expression was down-regulated but positively correlated with poor outcome in human cancers.
    Hu Q; Chen J; Yang W; Xu M; Zhou J; Tan J; Huang T
    Front Oncol; 2023; 13():990551. PubMed ID: 36845676
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Redox homeostasis of breast cancer lineages contributes to differential cell death response to exogenous hydrogen peroxide.
    Hecht F; Cazarin JM; Lima CE; Faria CC; Leitão AA; Ferreira AC; Carvalho DP; Fortunato RS
    Life Sci; 2016 Aug; 158():7-13. PubMed ID: 27328417
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Insights into the Role of Glutathione Peroxidase 3 in Non-Neoplastic Diseases.
    Zhang N; Liao H; Lin Z; Tang Q
    Biomolecules; 2024 Jun; 14(6):. PubMed ID: 38927092
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.